Musk frizzled-like domain is critical for mammalian neuromuscular junction formation and maintenance

Journal of Neuroscience

Volumn 35, Issue 12, 2015, Pages 4926-4941

  Messéant, Julien ^a   Dobbertin, Alexandre ^a   Girard, Emmanuelle ^b   Delers, Perrine ^a   Manuel, Marin ^a   Mangione, Francesca ^c   Schmitt, Alain ^a   Le Denmat, Dominique ^c   Molgó, Jordi ^a   Zytnicki, Daniel ^a   Schaeffer, Laurent ^b   Legay, Claire ^a   Strochlic, Laure ^a  

^a CNRS   (France)

^b UNIVERSITÉ LYON 1   (France)

^c and Plateforme d'Imagerie du Vivant   (France)

Author keywords

Congenital myasthenic syndrome; Lithium chloride; MuSK; Neuromuscular junction; Synaptogenesis; Wnt

Indexed keywords

CHOLINERGIC RECEPTOR; LITHIUM CHLORIDE; MUSCLE SPECIFIC KINASE; PROTEIN KINASE; UNCLASSIFIED DRUG; WNT PROTEIN; ACETYLCHOLINESTERASE; FRZB PROTEIN; GLYCOPROTEIN; MUSK PROTEIN, MOUSE; PROTEIN TYROSINE KINASE;

ADULT; ANIMAL CELL; ARTICLE; BIOTINYLATION; COMPUTER ASSISTED TOMOGRAPHY; CYSTEINE RICH DOMAIN; ELECTRON MICROSCOPY; EMBRYO; FATIGUE; GRIP STRENGTH; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MOUSE; MUSCLE WEAKNESS; NEUROMUSCULAR JUNCTION DISORDER; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SYNAPSE VESICLE; SYNAPTOGENESIS; WESTERN BLOTTING; ANIMAL; CHEMISTRY; DRUG EFFECTS; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HAND STRENGTH; MALE; METABOLISM; MOTONEURON; MUTATION; MYASTHENIC SYNDROMES, CONGENITAL; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PRIMARY CELL CULTURE; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ACETYLCHOLINESTERASE; ANIMALS; ANIMALS, NEWBORN; FATIGUE; FEMALE; GLYCOPROTEINS; HAND STRENGTH; LITHIUM CHLORIDE; MALE; MICE; MICE, TRANSGENIC; MOTOR NEURONS; MUSCLE WEAKNESS; MUTATION; MYASTHENIC SYNDROMES, CONGENITAL; NEUROMUSCULAR JUNCTION; PREGNANCY; PRIMARY CELL CULTURE; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC;

EID: 84925880723     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3381-14.2015     Document Type: Article

References (56)

1. Abu-Baker A, Laganiere J, Gaudet R, Rochefort D, Brais B, Neri C, Dion PA, Rouleau GA (2013) Lithium chloride attenuates cell death in oculopharyngeal muscular dystrophy by perturbing Wnt/-catenin pathway. Cell Death Dis 4:e821. CrossRef Medline
2. Arber S, Burden SJ, Harris AJ (2002) Patterning of skeletal muscle. Curr Opin Neurobiol 12:100–103. CrossRef Medline
3. Avilés EC, Pinto C, Hanna P, Ojeda J, Pérez V, De Ferrari GV, Zamorano P, Albistur M, Sandoval D, Henríquez JP (2014) Frizzled-9 impairs acetylcholine receptor clustering in skeletal muscle cells. Front Cell Neurosci 8:110. CrossRef Medline
4. Barik A, Zhang B, Sohal GS, Xiong WC, Mei L (2014) Crosstalk between Agrin and Wnt signaling pathways in development of vertebrate neuro-muscular junction. Dev Neurobiol 74:828–838. CrossRef Medline
5. Berrih-Aknin S, Frenkian-Cuvelier M, Eymard B (2014) Diagnostic and clinical classification of autoimmune myasthenia gravis. J Autoimmun 48:143–148. CrossRef Medline
6. Birling MC, Dierich A, Jacquot S, Hérault Y, Pavlovic G (2012) Highly-efficient, fluorescent, locus directed cre and FlpO deleter mice on a pure C57BL/6N genetic background. Genes 50:482–489. CrossRef Medline
7. Bogdanik LP, Burgess RW (2011) A valid mouse model of AGRIN-associated congenital myasthenic syndrome. Hum Mol Genet 20:4617– 4633. CrossRef Medline
8. Bolte S, Cordelières FP (2006) A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224:213–232. CrossRef Medline
9. Burden SJ, Yumoto N, Zhang W (2013) The role of MuSK in synapse formation and neuromuscular disease. Cold Spring Harb Perspect Biol 5:a009167. CrossRef Medline
10. Cartaud A, Strochlic L, Guerra M, Blanchard B, Lambergeon M, Krejci E, Cartaud J, Legay C (2004) MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction. J Cell Biol 165:505–515. CrossRef Medline
11. Chevessier F, Girard E, Molgó J, Bartling S, Koenig J, Hantaï D, Witzemann V (2008) A mouse model for congenital myasthenic syndrome due to MuSK mutations reveals defects in structure and function of neuromuscular junctions. Hum Mol Genet 17:3577–3595. CrossRef Medline
12. Chevessier F, Peter C, Mersdorf U, Girard E, Krejci E, McArdle JJ, Witzemann V (2012) A new mouse model for the slow-channel congenital myasthenic syndrome induced by the AChR L221F mutation. Neurobiol Dis 45:851–861. CrossRef Medline
13. Chiu CT, Liu G, Leeds P, Chuang DM (2011) Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington’s disease. Neuropsycho-pharmacology 36:2406–2421. CrossRef Medline
14. DeChiara TM, Bowen DC, Valenzuela DM, Simmons MV, Poueymirou WT, Thomas S, Kinetz E, Compton DL, Rojas E, Park JS, Smith C, DiStefano PS, Glass DJ, Burden SJ, Yancopoulos GD (1996) The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85:501–512. CrossRef Medline
15. Engel AG, Fumagalli G (1982) Mechanisms of acetylcholine receptor loss from the neuromuscular junction. Ciba Found Symp 90:197–224. Medline
16. Gautam M, DeChiara TM, Glass DJ, Yancopoulos GD, Sanes JR (1999) Distinct phenotypes of mutant mice lacking agrin, MuSK, or rapsyn. Brain Res Dev Brain Res 114:171–178. CrossRef Medline
17. Gomez CM, Maselli R, Gundeck JE, Chao M, Day JW, Tamamizu S, Lasalde JA, McNamee M, Wollmann RL (1997) Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction. J Neurosci 17:4170–4179. Medline
18. Gordon LR, Gribble KD, Syrett CM, Granato M (2012) Initiation of synapse formation by Wnt-induced MuSK endocytosis. Development 139:1023– 1033. CrossRef Medline
19. Hantaï D, Nicole S, Eymard B (2013) Congenital myasthenic syndromes: an update. Curr Opin Neurol 26:561–568. CrossRef Medline
20. Heckmann R, Ludin HP (1982) Differentiation of spontaneous activity from normal and denervated skeletal muscle. J Neurol Neurosurg Psychiatry 45:331–336. CrossRef Medline
21. Henriquez JP, Webb A, Bence M, Bildsoe H, Sahores M, Hughes SM, Salinas PC (2008) Wnt signaling promotes AChR aggregation at the neuromuscular synapse in collaboration with agrin. Proc Natl Acad Sci U S A 105: 18812–18817. CrossRef Medline
22. Jing L, Lefebvre JL, Gordon LR, Granato M (2009) Wnt signals organize synaptic prepattern and axon guidance through the zebrafish unplugged/ MuSK receptor. Neuron 61:721–733. CrossRef Medline
23. Jones K, Wei C, Iakova P, Bugiardini E, Schneider-Gold C, Meola G, Woodgett J, Killian J, Timchenko NA, Timchenko LT (2012) GSK3 mediates muscle pathology in myotonic dystrophy. J Clin Invest 122: 4461–4472. CrossRef Medline
24. Kim N, Burden SJ (2008) MuSK controls where motor axons grow and form synapses. Nat Neurosci 11:19–27. CrossRef Medline
25. Kim N, Stiegler AL, Cameron TO, Hallock PT, Gomez AM, Huang JH, Hubbard SR, Dustin ML, Burden SJ (2008) Lrp4 is a receptor for Agrin and forms a complex with MuSK. Cell 135:334–342. CrossRef Medline
26. Klein PS, Melton DA (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A 93:8455–8459. CrossRef Medline
27. Kummer TT, Misgeld T, Sanes JR (2006) Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost. Curr Opin Neurobiol 16:74–82. CrossRef Medline
28. Laws N, Hoey A (2004) Progression of kyphosis in mdx mice. J Appl Physiol 97:1970–1977. CrossRef Medline
29. Lin W, Burgess RW, Dominguez B, Pfaff SL, Sanes JR, Lee KF (2001) Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse. Nature 410:1057–1064. CrossRef Medline
30. Liu Y, Sugiura Y, Wu F, Mi W, Taketo MM, Cannon S, Carroll T, Lin W (2012) -Catenin stabilization in skeletal muscles, but not in motor neurons, leads to aberrant motor innervation of the muscle during neuromuscular development in mice. Dev Biol 366:255–267. CrossRef Medline
31. Li XM, Dong XP, Luo SW, Zhang B, Lee DH, Ting AK, Neiswender H, Kim CH, Carpenter-Hyland E, Gao TM, Xiong WC, Mei L (2008) Retrograde regulation of motoneuron differentiation by muscle beta-catenin. Nat Neurosci 11:262–268. CrossRef Medline
32. Marques MJ, Conchello JA, Lichtman JW (2000) From plaque to pretzel: fold formation and acetylcholine receptor loss at the developing neuromuscular junction. J Neurosci 20:3663–3675. Medline
33. McCubrey JA, Steelman LS, Bertrand FE, Davis NM, Sokolosky M, Abrams SL, Montalto G, D’Assoro AB, Libra M, Nicoletti F, Maestro R, Basecke J, Rakus D, Gizak A, Demidenko ZN, Cocco L, Martelli AM, Cervello M (2014) GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget 5:2881–2911. Medline
34. Mihaylova V, Salih MM, Mukhtar MM, Abuzeid HA, El-Sadig SM, von der Hagen M, Huebner A, Nürnberg G, Abicht A, Müller JS, et al. (2009) Refinement of the clinical phenotype in musk-related congenital myasthenic syndromes. Neurology 73:1926–1928. CrossRef Medline
35. Okada K, Inoue A, Okada M, Murata Y, Kakuta S, Jigami T, Kubo S, Shiraishi H, Eguchi K, Motomura M, Akiyama T, Iwakura Y, Higuchi O, Yamanashi Y (2006) The muscle protein Dok-7 is essential for neuromuscular synaptogenesis. Science 312:1802–1805. CrossRef Medline
36. Punga AR, Maj M, Lin S, Meinen S, Rüegg MA (2011) MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity. Eur J Neurosci 33:890–898. CrossRef Medline
37. Schiaffino S, Sandri M, Murgia M (2007) Activity-dependent signaling pathways controlling muscle diversity and plasticity. J Physiol 22:269– 278. CrossRef Medline
38. Schou M (2001) Lithium treatment at 52. J Affect Disord 67:21–32. CrossRef Medline
39. Sigoillot SM, Bourgeois F, Lambergeon M, Strochlic L, Legay C (2010) ColQ controls postsynaptic differentiation at the neuromuscular junction. J Neurosci 30:13–23. CrossRef Medline
40. Slater CR, Fawcett PRW, Walls TJ, Lyons PR, Bailey SJ, Beeson D, Young C, Gardner-Medwin D (2006) Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with “limb-girdle myasthenia.” Brain J Neurol 129:2061–2076. CrossRef Medline
41. Stambolic V, Ruel L, Woodgett JR (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6:1664–1668. CrossRef Medline
42. Strochlic L, Falk J, Goillot E, Sigoillot S, Bourgeois F, Delers P, Rouvière J, Swain A, Castellani V, Schaeffer L, Legay C (2012) Wnt4 participates in the formation of vertebrate neuromuscular junction. PLoS One 7:e29976. CrossRef Medline
43. Takamori M (2012) Structure of the neuromuscular junction: function and cooperative mechanisms in the synapse. Ann N Y Acad Sci 1274:14–23. CrossRef Medline
44. Takamori M, Nakamura T, Motomura M (2013) Antibodies against Wnt receptor of muscle-specific tyrosine kinase in myasthenia gravis. J Neuroimmunol 254:183–186. CrossRef Medline
45. Wada A (2009) Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades. J Pharmacol Sci 110:14–28. CrossRef Medline
46. Wang J, Ruan NJ, Qian L, Lei WL, Chen F, Luo ZG (2008) Wnt/beta-catenin signaling suppresses Rapsyn expression and inhibits acetylcholine receptor clustering at the neuromuscular junction. J Biol Chem 283:21668– 21675. CrossRef Medline
47. Weatherbee SD, Anderson KV, Niswander LA (2006) LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction. Development 133:4993–5000. CrossRef Medline
48. Webster RG, Cossins J, Lashley D, Maxwell S, Liu WW, Wickens JR, Martinez- Martinez P, de Baets M, Beeson D (2013) A mouse model of the slow channel myasthenic syndrome: neuromuscular physiology and effects of ephedrine treatment. Exp Neurol 248:286–298. CrossRef Medline
49. Wu H, Xiong WC, Mei L (2010) To build a synapse: signaling pathways in neuromuscular junction assembly. Development 137:1017–1033. CrossRef Medline
50. Wu H, Lu Y, Barik A, Joseph A, Taketo MM, Xiong WC, Mei L (2012a) β-Catenin gain of function in muscles impairs neuromuscular junction formation. Development 139:2392–2404. CrossRef Medline
51. Wu H, Lu Y, Shen C, Patel N, Gan L, Xiong WC, Mei L (2012b) Distinct roles of muscle and motoneuron LRP4 in neuromuscular junction formation. Neuron 75:94–107. CrossRef Medline
52. Yang X, Arber S, William C, Li L, Tanabe Y, Jessell TM, Birchmeier C, Burden SJ (2001) Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation. Neuron 30:399–410. CrossRef Medline
53. Yong Y, Ding H, Fan Z, Luo J, Ke ZJ (2011) Lithium fails to protect dopaminergic neurons in the 6-OHDA model of Parkinson’s disease. Neurochem Res 36:367–374. CrossRef Medline
54. Zhang B, Luo S, Wang Q, Suzuki T, Xiong WC, Mei L (2008) LRP4 serves as a coreceptor of agrin. Neuron 60:285–297. CrossRef Medline
55. Zhang B, Liang C, Bates R, Yin Y, Xiong WC, Mei L (2012) Wnt proteins regulate acetylcholine receptor clustering in muscle cells. Mol Brain 5:7. CrossRef Medline
56. Zhang W, Coldefy AS, Hubbard SR, Burden SJ (2011) Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK). J Biol Chem 286:40624–40630. CrossRef Medline